TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bio-Works Sweden AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,217
|
3,956
|
3,718 |
| Financial expenses |
1
|
0
|
2 |
| Earnings before taxes |
-3,066
|
-4,686
|
-3,756 |
| EBITDA |
-3,040
|
-4,708
|
-3,789 |
| Total assets |
1,909
|
2,215
|
3,743 |
| Current assets |
1,751
|
1,991
|
3,525 |
| Current liabilities |
632
|
1,404
|
1,919 |
| Equity capital |
1,277
|
811
|
1,824 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
31
|
33
|
35 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
66.9%
|
36.6%
|
48.7% |
| Turnover per employee |
72
|
120
|
106 |
| Profit as a percentage of turnover |
-138.3%
|
-118.5%
|
-101.0% |
| Return on assets (ROA) |
-160.6%
|
-211.6%
|
-100.3% |
| Current ratio |
277.1%
|
141.8%
|
183.7% |
| Return on equity (ROE) |
-240.1%
|
-577.8%
|
-205.9% |
| Change turnover |
-1,605
|
227
|
1,744 |
| Change turnover % |
-42%
|
6%
|
88% |
| Chg. No. of employees |
-2
|
-2
|
8 |
| Chg. No. of employees % |
-6%
|
-6%
|
30% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.